Slideshow
Author(s):
OI may serve for research purposes as a simple and inexpensive indicator of evolving AD pathology. Details here.
This Week on NeurologyLive® — October 21, 2024
Episode 126: Exploring the Therapeutic Potential of ATH434 in Multiple System Atrophy
Understanding the Therapeutic Potential of GT-02287 in GBA-Parkinson Disease
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
FDA Action Update, September 2024: Approvals, Designations, and Clearances
European Commission Grants NLX-112 Orphan Medicinal Product Designation for Spinocerebellar Ataxia